Redwood City, CA, United States of America

Bruce H Morimoto

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Supergen, Inc. Active years: 2002-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bruce H Morimoto. Retrieved from https://idiyas.com/inventor/bruce-h-morimoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2002-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Bruce H Morimoto: A Pioneer in Pharmaceutical Innovations

Introduction

Bruce H Morimoto, an accomplished inventor based in Redwood City, California, has made significant contributions to the field of pharmaceuticals. With a total of two patents to his name, Morimoto's work primarily focuses on enhancing the bioavailability of therapeutic agents through innovative chemical formulations. His research has the potential to impact the effectiveness of various medications.

Latest Patents

Morimoto's latest patents include groundbreaking developments in the area of prodrug derivatives and surfactants. One of his prominent inventions is the patent for "Phosphocholine linked prodrug derivatives," which discloses novel compounds designed to function as prodrugs. These compounds increase the bioavailability of linked therapeutic agents by utilizing various linkers, including substituted or unsubstituted alkyl and alkenyl groups. The patent outlines methods for preparing these compounds that contain therapeutic agents, such as alcohol-containing water-insoluble steroids.

Another notable patent is for "Phosphocholine surfactants and their use," which describes a pharmaceutical formulation that incorporates a sterol phosphocholine surfactant. This formulation is intended for use with pharmaceutically active agents that are insoluble or sparingly soluble in water, further showcasing Morimoto's expertise in creating effective pharmaceutical solutions.

Career Highlights

Bruce H Morimoto currently works at Supergen, Inc., where he has been instrumental in advancing the company's pharmaceutical innovations. His dual focus on both drug formulation and bioavailability has allowed Supergen, Inc. to pursue unique approaches in drug delivery, targeting improvements in patient outcomes.

Collaborations

Throughout his career, Morimoto has collaborated with notable colleagues, including Peter L Barker and Vincent S Hernandez. These partnerships have further enriched his innovative efforts and contributed positively to the research environment at Supergen, Inc.

Conclusion

In summary, Bruce H Morimoto's contributions to the field of pharmaceuticals through his inventive patents and collaborations underscore his role as a vital force in the ongoing pursuit of enhanced medical treatments. His work lays the foundation for future advancements in drug formulations aimed at improving patient accessibility and outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…